These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6191336)

  • 41. [Effects of a protease inhibitor on hemolytic shock from incompatible blood in rabbits. Experimental research].
    Laurentaci G; Monosi V
    Osp Ital Chir; 1967 Sep; 17(3):247-73. PubMed ID: 5306328
    [No Abstract]   [Full Text] [Related]  

  • 42. Modified paper chromatographic method for assay of myocardial depressant factor.
    Yamada T; Pettit GW
    Circ Shock; 1977; 4(4):379-86. PubMed ID: 598007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of plasma peptides to the myocardial depressant factor in hemorrhagic shock in cats.
    Lefer AM; Martin J
    Circ Res; 1970 Jan; 26(1):59-69. PubMed ID: 5308083
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of lysosomes in circulatory shock.
    Lefer AM
    Life Sci; 1976 Dec; 19(12):1803-9. PubMed ID: 794609
    [No Abstract]   [Full Text] [Related]  

  • 45. [Serial changes in myocardial depressant factor (Lefer) activities in cardiogenic shock].
    Okuda N; Yamada T; Hashizume T; Hosono K
    Rinsho Byori; 1974 Oct; 22(10 Suppl):6. PubMed ID: 4475976
    [No Abstract]   [Full Text] [Related]  

  • 46. Reversibility of mitochondrial metabolic response to circulatory shock and tissue ischemia.
    Mela L
    Circ Shock Suppl; 1979; 1():61-7. PubMed ID: 288534
    [No Abstract]   [Full Text] [Related]  

  • 47. [Modification of plasma enzyme levels in experimental hemorrhagic shock due to trasylol].
    Horpácsy G; Barankay T; Nagy S; Szabó I; Benló K
    Med Welt; 1973 Mar; 24(12):459-61. PubMed ID: 4540731
    [No Abstract]   [Full Text] [Related]  

  • 48. Protective action of a protease inhibitor in hemorrhagic shock.
    Glenn TM; Herlihy BL; Lefer AM
    Arch Int Pharmacodyn Ther; 1973 Jun; 203(2):292-304. PubMed ID: 4542687
    [No Abstract]   [Full Text] [Related]  

  • 49. [Protective effect of reduced glutathione on reticuloendothelial function in hemorrhagic shock (author's transl)].
    Suzuki C; Ogawa R; Fujita T
    Masui; 1980 Mar; 29(3):212-6. PubMed ID: 7373838
    [No Abstract]   [Full Text] [Related]  

  • 50. Role of lysosomal instability in the development of refractory shock.
    Bell ML; Herman AH; Smith EE; Egdahl RH; Rutenburg AM
    Surgery; 1971 Sep; 70(3):341-7. PubMed ID: 5568517
    [No Abstract]   [Full Text] [Related]  

  • 51. Metabolic deterioration in shock state and its modulation.
    Yoshitake J; Nomoto Y; Kono S; Takasugi S; Tada S; Yoshimura N; Oda T
    Prog Clin Biol Res; 1983; 111():21-38. PubMed ID: 6306680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influence of the spleen and of the reticulo-histiocyte system on the experimental hemorrhagic shock evolution].
    Novelli GP; Cortesini C; Pagni E; Perna AM; Pagliai P
    Acta Anaesthesiol; 1969; 20(2):221-41. PubMed ID: 5409222
    [No Abstract]   [Full Text] [Related]  

  • 53. Isolation of a shock-induced circulating cardiodepressant substance.
    Goldfarb RD; Weber P; Eisenman J
    Am J Physiol; 1979 Aug; 237(2):H168-77. PubMed ID: 464108
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of suppression of endocrine or exocrine pancreatic function in hemorrhagic shock.
    Galvin MJ; Lefer AM
    Experientia; 1979 Jan; 35(1):55-6. PubMed ID: 369876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic changes in the intestinal mucosa during hemorrhagic shock.
    Bounous G
    Can J Surg; 1965 Oct; 8(4):332-9. PubMed ID: 5294426
    [No Abstract]   [Full Text] [Related]  

  • 56. Depression of myocardial contractility is not a causative factor for circulatory deterioration in two experimental models of shock in anesthetized dogs.
    Jacinto SM; Jandhyala BS
    Ann N Y Acad Sci; 1994 Jun; 723():345-8. PubMed ID: 8030881
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current status of the myocardial depressant factor (MDF) and shock].
    Favaro R; Pelaia P
    Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiac dynamics following shock: role of circulating cardiodepressant substances.
    Goldfarb RD
    Circ Shock; 1982; 9(3):317-34. PubMed ID: 7094223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Role of biologically active substances in the pathogenesis of endotoxim shock].
    Bardakhch'ian EA; Kirichenko IuG
    Patol Fiziol Eksp Ter; 1983; (1):79-84. PubMed ID: 6341956
    [No Abstract]   [Full Text] [Related]  

  • 60. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.